posted
The U.S. Food and Drug Administration today announced it will require the manufacturers of antiepileptic drugs to add to these products' prescribing information, or labeling, a warning that their use increases risk of suicidal thoughts and behaviors (suicidality). The action includes all antiepileptic drugs including those used to treat psychiatric disorders, migraine headaches and other conditions, as well as epilepsy. FDA Public AnnouncementPosts: 5609 | Registered: Jan 2003
| IP: Logged |
posted
Thanks for posting this, Shan. Here's the list of actual drugs.
Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR) Clonazepam (marketed as Klonopin) Clorazepate (marketed as Tranxene) Divalproex sodium (marketed as Depakote, Depakote ER) Ethosuximide (marketed as Zarontin) Ethotoin (marketed as Peganone) Felbamate (marketed as Felbatol) Gabapentin (marketed as Neurontin) Lamotrigine (marketed as Lamictal) Lacosamide (marketed as Vimpat) Levetiracetam (marketed as Keppra) Mephenytoin (marketed as Mesantoin) Methosuximide (marketed as Celontin) Oxcarbazepine (marketed as Trileptal) Phenytoin (marketed as Dilantin) Pregabalin (marketed as Lyrica) Primidone (marketed as Mysoline) Rufinamide (marketed as Banzel) Tiagabine (marketed as Gabitril) Topiramate (marketed as Topamax) Trimethadione (marketed as Tridione) Valproic Acid (marketed as Depakene, Stavzor Extended Release Tablets) Zonisamide (marketed as Zonegran)
A lot of them are prescribed for all kinds of things, from poor sleep, to anxiety, to migraine.
Posts: 6246 | Registered: Aug 2004
| IP: Logged |
Printer-friendly view of this topic
